Fang et al. 4 have demonstrated in cancer cell lines that BRAF oncogenic mutations mediate the CpG island methylation phenotype (CIMP) resulting in hypermethylation at MLH1 and other CIMP marker genes, via the transcriptional repressor MAFG4. Here, BRAF is linked to cancer.